admin

admin

Regeneron expands into eye care with Oxular (REGN:NASDAQ)

RapidEye Regeneron Pharmaceuticals (NASDAQ:RAIN), maker of eye disease therapy Eylea, has acquired Oxular, a UK-based biotech drug maker focused on ophthalmology. While neither company has officially disclosed the deal, former Oxular CEO Mark Gaffney, who currently leads Calluna Pharma's immune…

Ralph Lauren Corporation (RL) Stock Outlook

Summary Our stock/bond asset allocation model, which we call the Stock-Bond Barometer, identifies bonds as the asset class that offers the most value at the current point in the market. Our model considers real-time levels, growth rates, and forecasts of…